Why the study?
Does catheter ablation in conjunction with immunosuppression successfully treat ventricular tachycardia storm in a patient with cardiac sarcoidosis?
Does catheter ablation in conjunction with immunosuppression successfully treat ventricular tachycardia storm in a patient with cardiac sarcoidosis?
Catheter ablation combined with immunosuppression may be an effective strategy for managing refractory ventricular tachycardia storm in patients with cardiac sarcoidosis.
May support combined ablation-immunosuppression for refractory VT in cardiac sarcoidosis; hypothesis-generating and should not yet change practice.
Ventricular Tachycardia Storm in Cardiac Sarcoidosis. We describe the case of a 43-year-old male with cardiac sarcoidosis and ventricular tachycardia storm successfully treated with catheter ablation and immunosuppression. Antiarrhythmics alone, and in combination with immusuppressive agents, failed to successfully manage the ventricular tachycardia episodes. Catheter ablation in conjunction with immunosuppression proved to be the most successful treatment strategy. The reported efficacy of catheter ablation for ventricular tachycardia in cardiac sarcoidosis is variable. (J Cardiovasc Electrophysiol, Vol. 22, pp. 210-213, February 2011)
No takes yet. Share an insight, caveat, or question.
Stees et al. (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: